Dengue drug trial pulled before it even started
NCT ID NCT03875560
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to test a drug called IC14 in adults with early dengue fever to see if it is safe and could help reduce symptoms and viral levels. It was designed for people in areas where dengue is common, but the trial was withdrawn before any participants were enrolled. No results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENGUE FEVER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a dengue vaccine be both Cost-Effective and trusted? a thai study investigates
- Dengue vaccine booster put to the test: can it shield against all four virus types?
- Flu drug zanamivir tested against Dengue's deadliest complication
- AI toolkit aims to speed up epidemic response for diseases like COVID-19 and mpox
- Could a new vaccine shield infants from dengue?
- Ultrasound clues could predict dangerous dengue